Amy Jones, Ovation’s Genetics scientific director will be joined by Nathan Treff, chief scientific officer of Genomic Prediction, to discuss state-of-the art LifeViewTM genetic screening options, PGT-A+ and PGT-P. PGT-A+ combines copy number and genotyping data to provide the most accurate, highest-resolution prediction of chromosomal abnormalities available. PGT-P provides an Embryo Health Score, ranking euploid embryos based on their risk of polygenic disorders, including certain cancers, diabetes and heart disease.
